期刊
JOURNAL OF HEPATOLOGY
卷 35, 期 4, 页码 474-481出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(01)00169-6
关键词
hepatic stellate cells; liver fibrosis; Na+/Ca2+ exchanger; ROCK
Background/Aims: Activation of hepatic stellate cells (HSCs) is a final common pathway of liver fibrosis. Recently, it has been demonstrated that the small GTPase Rho is involved in HSCs activation, and that Y-27632, an inhibitor of Rho-kinase which is an effector that acts downstream of Rho, inhibits Rho-associated effects. The objective of the current study was to investigate the inhibitory effects of Y-27632 on the activation of HSCs and the progression of liver fibrosis. Methods: Y-27632 (1, 10, 100 muM) was added to HSCs isolated from normal rat liver. Results: HSCs maintained the 'star-like' configuration of the quiescent stage in the presence of Y-27632, as well as inhibition of the expression of Na+/Ca2+ exchanger mRNA which was reported to be an indicator of HSCs activation. In addition, when Y-27632 (30 mg/kg body weight) was administered to rats with carbon tetrachloride-induced liver fibrosis, collagen deposition was inhibited, the hepatic hydroxyproline content was decreased, and the serum hyaluronic acid level was reduced. Moreover, Y-27632 reduced the number of smooth muscle alpha -actin-positive cells and transforming growth factor-beta1-positive cells, and inhibited the expression of Na+/Ca2+ exchanger mRNA. Conclusions: These findings indicate that Y-27632 may be useful for the clinical management of liver fibrosis. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据